ClinicalTrials.gov
ClinicalTrials.gov Menu

SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00361959
Recruitment Status : Completed
First Posted : August 9, 2006
Last Update Posted : January 20, 2017
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2006
  Actual Study Completion Date : February 2006
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):